Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 3496 to 3510 of 8238 results

  1. Reusing our content

    Find out how and where you can reuse NICE's content. Includes use of our content in the UK, use of our content internationally, use of our content for AI purposes, our content assurance process, and our information asset register.

  2. Research to access pathway for investigational drugs for COVID-19 (RAPID C-19)

    RAPID C-19’s role in reviewing potential COVID-19 treatments has now ended because we have moved back to routine commissioning arrangements for these treatments.

  3. Privacy notice

    How we collect and use your personal information, and your rights under data protection legislation.

  4. Patient safety

    Our guidelines make evidence based, best practice recommendations. These help to improve patient safety and reduce the risk of harm across the health system.

  5. NICE newsletters and alerts

    Subscribe to NICE newsletters and alerts for the latest healthcare guidance, clinical updates, and evidence-based resources across health and social care.

  6. Case studies

    Home What NICE does NICE International {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1

  7. NICE Advice: working on your objectives

    If you’re unsure where to start or your circumstances are unique, we encourage you to get in touch. We’ll work with you to unpick your challenges and find a solution that meets your needs.

  8. Single technology appraisal (STA) timeline

    A step-by-step timeline of the process we used to develop single technology appraisals (STA).

  9. About evidence summaries

    Summaries of the best available evidence for selected medicines that are considered to be of significance to the NHS.

  10. Process timeline for HealthTech guidance

    An approximate guide to the timings for the development of a piece of HealthTech guidance.

  11. Get a HealthTech evaluated

    Our Medical Technologies Evaluation Programme (MTEP) considers technologies that could offer benefits to patients and the health and social care system over current practice.

  12. How we develop HealthTech guidance

    Our Medical Technologies Evaluation Programme (MTEP) evaluates new HealthTech.

  13. Get involved with HealthTech guidance

    We want you to be involved in our work - whether you’re commenting on our draft recommendations, taking part in guidance development or attending a committee meeting, your voice is important to us.

  14. Methods research areas

    NICE priority methodological research areas.

  15. Supplier information

    Check our list of appointed suppliers to find out which knowledge resources and services they can offer.